OpenLegislation

Part 2 Manufacturing, wholesale dealing and brokeringF1

  1. 2Wholesale dealer's licence used to distribute a medicinal product imported from an EEA State before IP completion day
  2. 3Approved country for import list on IP completion day (regulation 18A)
  3. 4Qualified persons and approved country for batch testing list on IP completion day (Schedule 7)
  4. 5List of countries with equivalent regulatory standards as to the manufacturing of active substances on IP completion day (regulation 45O(6) to (9))

Annotations

Textual amendments

F1

Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)